Keeping cancer clinical research on track during a pandemic: A case study from Dana-Farber Cancer Institute

Study details how actions taken at Dana-Farber enabled cancer clinical trials to stay on track during pandemic.
Even as the Covid-19 pandemic tested the country´s health care system as never before, clinical research in cancer stayed largely on course at many cancer centers. At Dana-Farber Cancer Institute, which adopted alternatives to in-person visits for clinical trial participants as the pandemic surged, researchers have issued a scientific report ...